Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study
Haemophilia · 2025
DOI: 10.1111/hae.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2025. Verfasst von Anna Olsson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Region Västra Götaland, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Menorrhagia, von Willebrand Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Investigator Initiated Research grant from CSL Behring AB and Vifor (International) AG.
Abstract (Originalsprache)
Introduction
Heavy menstrual bleeding (HMB) is a common and burdensome symptom in women with von Willebrand disease (VWD). Although VWD and HMB have been studied, the prevalence and impact of HMB across different age groups remains underexplored.
Aim
To investigate the prevalence and impact of HMB in women with VWD across different age groups.
Methods
This retrospective nationwide study included 136 women aged 18–55 years with type 1 (von Willebrand factor activity ≤ 0.35 IU/mL), 2 or 3 VWD. Data were collected using a questionnaire assessing HMB and its impact on life, and clinical data were retrieved from medical records.
Results
HMB was reported by 93% of women in one or more age groups. During adolescence, 85% reported HMB. Reported HMB decreased with age: 63% at 20–29 years, 45% at 30–39 years, and 36% at 40–55 years. Of the 136 women, 60% had sought medical care due to HMB. Forty‐nine percent of these had sought medical care at two or more healthcare facilities. The majority (86%) stated that HMB had negatively impacted their lives. Several aspects were affected, including school/work performance, social and physical activities, with a decreasing impact observed with increasing age. Despite the use of hormonal therapy (76%) and/or haemostatic agents (76%), 54% had had iron deficiency. Thirty‐five percent were diagnosed after age 19, and 27% were lost to follow‐up.
Conclusions
The findings emphasise the need for increased awareness during adolescence, more structured follow‐up and improved individualised management strategies to prevent and treat HMB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Region Västra Götaland, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Internal Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Coagulation Center, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
- Region Skåne, Department of Hematology, Skåne University Hospital, Oncology and Medical Physics, Malmö, Sweden.
- Sahlgrenska Academy, Institution for Nursing Science and Health at Gothenburg University, Gothenburg, Sweden.
Förderung
- Investigator Initiated Research grant from CSL Behring AB and Vifor (International) AG
Zitieren
APA
Olsson, A., Elfvinge, P., Zetterberg, E., & Myrin-Westesson, L. (2025). Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study. Haemophilia. https://doi.org/10.1111/hae.70127
Vancouver
Olsson A, Elfvinge P, Zetterberg E, Myrin-Westesson L. Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study. Haemophilia. 2025. doi:10.1111/hae.70127
BibTeX
@article{Olsson2025,
author = {Olsson, Anna and Elfvinge, Petra and Zetterberg, Eva and Myrin-Westesson, Linda},
title = {Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.70127}
}
EUVIMED